Global Prostate Cancer Diagnosis and Treatment Market 2020 by Company, Type and Application, Forecast to 2025

  • receipt Report ID : 2377
  • calendar_today Published On: Jul, 2020
  • file_copy Pages: 156
  • list Market Research
Buy @ $3500

Market Overview

The global Prostate Cancer Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Prostate Cancer Diagnosis and Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Prostate Cancer Diagnosis and Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Prostate Cancer Diagnosis and Treatment market has been segmented into Prostate specific antigen test (PSA), Digital rectal exam (DRE), etc.

Breakdown by Application, Prostate Cancer Diagnosis and Treatment has been segmented into Hospitals, Diagnostic clinics, Research centers, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Prostate Cancer Diagnosis and Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Prostate Cancer Diagnosis and Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prostate Cancer Diagnosis and Treatment market.

For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Prostate Cancer Diagnosis and Treatment Market Share Analysis

Prostate Cancer Diagnosis and Treatment competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Prostate Cancer Diagnosis and Treatment revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prostate Cancer Diagnosis and Treatment revenue and market share for each player covered in this report.

The major players covered in Prostate Cancer Diagnosis and Treatment are: Abbott Laboratories, Bayer, Amgen, AbbVie, Bavarian Nordic, Active Biotech, Dendreon, AstraZeneca, Astellas Pharma, Bristol-Myers Squibb, Ipsen, Sanofi, Endo, Takeda, Johnson & Johnson, GSK, Ferring Pharmaceuticals, Siemens Healthineers, Pfizer, GE Healthcare, Teva Pharmaceutical, Tolmar Pharmaceuticals, etc. Among other players domestic and global, Prostate Cancer Diagnosis and Treatment market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers

Abbott Laboratories

Bayer

Amgen

AbbVie

Bavarian Nordic

Active Biotech

Dendreon

AstraZeneca

Astellas Pharma

Bristol-Myers Squibb

Ipsen

Sanofi

Endo

Takeda

Johnson & Johnson

GSK

Ferring Pharmaceuticals

Siemens Healthineers

Pfizer

GE Healthcare

Teva Pharmaceutical

Tolmar Pharmaceuticals

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:

Prostate specific antigen test (PSA)

Digital rectal exam (DRE)

Market segment by Application, can be divided into

Hospitals

Diagnostic clinics

Research centers

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Product Overview and Scope of Prostate Cancer Diagnosis and Treatment

1.2 Classification of Prostate Cancer Diagnosis and Treatment by Type

1.2.1 Overview: Global Prostate Cancer Diagnosis and Treatment Revenue by Type: 2015 Versus 2019 Versus 2025

1.2.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type in 2019

1.2.3 Prostate specific antigen test (PSA)

1.2.4 Digital rectal exam (DRE)

1.3 Global Prostate Cancer Diagnosis and Treatment Market by Application

1.3.1 Overview: Global Prostate Cancer Diagnosis and Treatment Revenue by Application: 2015 Versus 2019 Versus 2025

1.3.2 Hospitals

1.3.3 Diagnostic clinics

1.3.4 Research centers

1.4 Global Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

1.5 Global Prostate Cancer Diagnosis and Treatment Market Size by Regions: 2015 VS 2019 VS 2025

1.6 Global Prostate Cancer Diagnosis and Treatment Market Size by Regions (2015-2020)

1.7 Global Prostate Cancer Diagnosis and Treatment Market Size and Forecast by Regions (2020-2025)

1.7.1 North America Prostate Cancer Diagnosis and Treatment Status and Prospect (2015-2025)

1.7.2 Europe Prostate Cancer Diagnosis and Treatment Status and Prospect (2015-2025)

1.7.3 Asia Prostate Cancer Diagnosis and Treatment Status and Prospect (2015-2025)

1.7.4 South America Prostate Cancer Diagnosis and Treatment Status and Prospect (2015-2025)

1.7.5 Middle East & Africa Prostate Cancer Diagnosis and Treatment Status and Prospect (2015-2025)

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Abbott Laboratories SWOT Analysis

2.1.4 Abbott Laboratories Product and Services

2.1.5 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.2 Bayer

2.2.1 Bayer Details

2.2.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Bayer SWOT Analysis

2.2.4 Bayer Product and Services

2.2.5 Bayer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.3 Amgen

2.3.1 Amgen Details

2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Amgen SWOT Analysis

2.3.4 Amgen Product and Services

2.3.5 Amgen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.4 AbbVie

2.4.1 AbbVie Details

2.4.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 AbbVie SWOT Analysis

2.4.4 AbbVie Product and Services

2.4.5 AbbVie Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.5 Bavarian Nordic

2.5.1 Bavarian Nordic Details

2.5.2 Bavarian Nordic Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Bavarian Nordic SWOT Analysis

2.5.4 Bavarian Nordic Product and Services

2.5.5 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.6 Active Biotech

2.6.1 Active Biotech Details

2.6.2 Active Biotech Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Active Biotech SWOT Analysis

2.6.4 Active Biotech Product and Services

2.6.5 Active Biotech Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.7 Dendreon

2.7.1 Dendreon Details

2.7.2 Dendreon Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Dendreon SWOT Analysis

2.7.4 Dendreon Product and Services

2.7.5 Dendreon Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.8 AstraZeneca

2.8.1 AstraZeneca Details

2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 AstraZeneca SWOT Analysis

2.8.4 AstraZeneca Product and Services

2.8.5 AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.9 Astellas Pharma

2.9.1 Astellas Pharma Details

2.9.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Astellas Pharma SWOT Analysis

2.9.4 Astellas Pharma Product and Services

2.9.5 Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.10 Bristol-Myers Squibb

2.10.1 Bristol-Myers Squibb Details

2.10.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Bristol-Myers Squibb SWOT Analysis

2.10.4 Bristol-Myers Squibb Product and Services

2.10.5 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.11 Ipsen

2.11.1 Ipsen Details

2.11.2 Ipsen Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Ipsen SWOT Analysis

2.11.4 Ipsen Product and Services

2.11.5 Ipsen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.12 Sanofi

2.12.1 Sanofi Details

2.12.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 Sanofi SWOT Analysis

2.12.4 Sanofi Product and Services

2.12.5 Sanofi Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.13 Endo

2.13.1 Endo Details

2.13.2 Endo Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Endo SWOT Analysis

2.13.4 Endo Product and Services

2.13.5 Endo Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.14 Takeda

2.14.1 Takeda Details

2.14.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis

2.14.3 Takeda SWOT Analysis

2.14.4 Takeda Product and Services

2.14.5 Takeda Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.15 Johnson & Johnson

2.15.1 Johnson & Johnson Details

2.15.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis

2.15.3 Johnson & Johnson SWOT Analysis

2.15.4 Johnson & Johnson Product and Services

2.15.5 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.16 GSK

2.16.1 GSK Details

2.16.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis

2.16.3 GSK SWOT Analysis

2.16.4 GSK Product and Services

2.16.5 GSK Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.17 Ferring Pharmaceuticals

2.17.1 Ferring Pharmaceuticals Details

2.17.2 Ferring Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis

2.17.3 Ferring Pharmaceuticals SWOT Analysis

2.17.4 Ferring Pharmaceuticals Product and Services

2.17.5 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.18 Siemens Healthineers

2.18.1 Siemens Healthineers Details

2.18.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis

2.18.3 Siemens Healthineers SWOT Analysis

2.18.4 Siemens Healthineers Product and Services

2.18.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.19 Pfizer

2.19.1 Pfizer Details

2.19.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis

2.19.3 Pfizer SWOT Analysis

2.19.4 Pfizer Product and Services

2.19.5 Pfizer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.20 GE Healthcare

2.20.1 GE Healthcare Details

2.20.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis

2.20.3 GE Healthcare SWOT Analysis

2.20.4 GE Healthcare Product and Services

2.20.5 GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.21 Teva Pharmaceutical

2.21.1 Teva Pharmaceutical Details

2.21.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis

2.21.3 Teva Pharmaceutical SWOT Analysis

2.21.4 Teva Pharmaceutical Product and Services

2.21.5 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

2.22 Tolmar Pharmaceuticals

2.22.1 Tolmar Pharmaceuticals Details

2.22.2 Tolmar Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis

2.22.3 Tolmar Pharmaceuticals SWOT Analysis

2.22.4 Tolmar Pharmaceuticals Product and Services

2.22.5 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Prostate Cancer Diagnosis and Treatment Market Size by Players (2015-2020)

3.2 China Prostate Cancer Diagnosis and Treatment Market Size by Players (2015-2020)

3.3 Market Concentration Rate

3.3.1 Top 5 Prostate Cancer Diagnosis and Treatment Players Market Share

3.3.2 Top 10 Prostate Cancer Diagnosis and Treatment Players Market Share

4 North America Market Size and Forecast by Countries

4.1 North America Prostate Cancer Diagnosis and Treatment Market Size by Countries (2015-2020)

4.2 North America Prostate Cancer Diagnosis and Treatment Market Size and Forecast by Countries (2015-2026)

4.3 United States Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

4.4 Canada Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

4.5 Mexico Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

5.1 Europe Prostate Cancer Diagnosis and Treatment Market Size by Countries (2015-2020)

5.2 Europe Prostate Cancer Diagnosis and Treatment Market Size and Forecast by Countries (2015-2026)

5.3 Germany Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

5.4 France Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

5.5 UK Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

5.6 Russia Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

5.7 Italy Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

6.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Regions (2015-2020)

6.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size and Forecast by Regions (2015-2026)

6.3 China Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

6.4 Japan Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

6.5 Korea Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

6.6 India Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

6.7 Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

7.1 South America Prostate Cancer Diagnosis and Treatment Market Size by Countries (2015-2020)

7.2 South America Prostate Cancer Diagnosis and Treatment Market Size and Forecast by Countries (2015-2026)

7.3 Brazil Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

7.4 Argentina Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

8.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue by Regions (2015-2020)

8.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size and Forecast by Countries (2015-2026)

8.3 Saudi Arabia Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

8.4 UAE Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

8.5 Egypt Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

8.6 South Africa Prostate Cancer Diagnosis and Treatment Market Size and Forecast (2015-2025)

9 Market Size Segment by Type

9.1 Global Prostate Cancer Diagnosis and Treatment Market Size and Forecast by Type (2015-2025)

9.1.1 Global Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)

9.1.2 Global Prostate Cancer Diagnosis and Treatment Market Size Forecast by Type (2020-2025)

9.2 China Prostate Cancer Diagnosis and Treatment Market Size and Forecast by Type (2015-2025)

9.2.1 China Prostate Cancer Diagnosis and Treatment Market Size by Type (2015-2020)

9.2.2 China Prostate Cancer Diagnosis and Treatment Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application

10.1 Global Prostate Cancer Diagnosis and Treatment Market Size and Forecast by Application (2015-2025)

10.1.1 Global Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)

10.1.2 Global Prostate Cancer Diagnosis and Treatment Market Size Forecast by Application (2020-2025)

10.2 China Prostate Cancer Diagnosis and Treatment Market Size and Forecast by Application (2015-2025)

10.2.1 China Prostate Cancer Diagnosis and Treatment Market Size by Application (2015-2020)

10.2.2 China Prostate Cancer Diagnosis and Treatment Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Data Source

12.3 Disclaimer

12.4 About US

List of Tables

Table 1. Global Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025

Table 2. Breakdown of Prostate Cancer Diagnosis and Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025

Table 4. Global Market Prostate Cancer Diagnosis and Treatment Market Size (USD Million) Comparison by Regions (2020-2025)

Table 5. Global Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Regions (2015-2020)

Table 6. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Regions (2015-2020)

Table 7. Global Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Regions (2020-2025)

Table 8. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Regions (2020-2025)

Table 9. Abbott Laboratories Corporate Information, Location and Competitors

Table 10. Abbott Laboratories Major Business

Table 11. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 12. Abbott Laboratories SWOT Analysis

Table 13. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 14. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 15. Bayer Corporate Information, Location and Competitors

Table 16. Bayer Major Business

Table 17. Bayer Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2018-2019)

Table 18. Bayer SWOT Analysis

Table 19. Bayer Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 20. Bayer Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 21. Amgen Corporate Information, Location and Competitors

Table 22. Amgen Major Business

Table 23. Amgen Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 24. Amgen SWOT Analysis

Table 25. Amgen Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 26. Amgen Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 27. AbbVie Corporate Information, Location and Competitors

Table 28. AbbVie Major Business

Table 29. AbbVie Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 30. AbbVie SWOT Analysis

Table 31. AbbVie Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 32. AbbVie Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 33. Bavarian Nordic Corporate Information, Location and Competitors

Table 34. Bavarian Nordic Major Business

Table 35. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 36. Bavarian Nordic SWOT Analysis

Table 37. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 38. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 39. Active Biotech Corporate Information, Location and Competitors

Table 40. Active Biotech Major Business

Table 41. Active Biotech Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 42. Active Biotech SWOT Analysis

Table 43. Active Biotech Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 44. Active Biotech Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 45. Dendreon Corporate Information, Location and Competitors

Table 46. Dendreon Major Business

Table 47. Dendreon Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 48. Dendreon SWOT Analysis

Table 49. Dendreon Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 50. Dendreon Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 51. AstraZeneca Corporate Information, Location and Competitors

Table 52. AstraZeneca Major Business

Table 53. AstraZeneca Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 54. AstraZeneca SWOT Analysis

Table 55. AstraZeneca Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 56. AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 57. Astellas Pharma Corporate Information, Location and Competitors

Table 58. Astellas Pharma Major Business

Table 59. Astellas Pharma Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 60. Astellas Pharma SWOT Analysis

Table 61. Astellas Pharma Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 62. Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 63. Bristol-Myers Squibb Corporate Information, Location and Competitors

Table 64. Bristol-Myers Squibb Major Business

Table 65. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 66. Bristol-Myers Squibb SWOT Analysis

Table 67. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 68. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 69. Ipsen Corporate Information, Location and Competitors

Table 70. Ipsen Major Business

Table 71. Ipsen Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 72. Ipsen SWOT Analysis

Table 73. Ipsen Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 74. Ipsen Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 75. Sanofi Corporate Information, Location and Competitors

Table 76. Sanofi Major Business

Table 77. Sanofi Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 78. Sanofi SWOT Analysis

Table 79. Sanofi Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 80. Sanofi Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 81. Endo Corporate Information, Location and Competitors

Table 82. Endo Major Business

Table 83. Endo Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 84. Endo SWOT Analysis

Table 85. Endo Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 86. Endo Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 87. Takeda Corporate Information, Location and Competitors

Table 88. Takeda Major Business

Table 89. Takeda Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 90. Takeda SWOT Analysis

Table 91. Takeda Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 92. Takeda Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 93. Johnson & Johnson Corporate Information, Location and Competitors

Table 94. Johnson & Johnson Major Business

Table 95. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 96. Johnson & Johnson SWOT Analysis

Table 97. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 98. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 99. GSK Corporate Information, Location and Competitors

Table 100. GSK Major Business

Table 101. GSK Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 102. GSK SWOT Analysis

Table 103. GSK Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 104. GSK Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 105. Ferring Pharmaceuticals Corporate Information, Location and Competitors

Table 106. Ferring Pharmaceuticals Major Business

Table 107. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 108. Ferring Pharmaceuticals SWOT Analysis

Table 109. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 110. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 111. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Type and Application

Table 112. Siemens Healthineers Major Business

Table 113. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 114. Siemens Healthineers SWOT Analysis

Table 115. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 116. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 117. Pfizer Corporate Information, Location and Competitors

Table 118. Pfizer Major Business

Table 119. Pfizer Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 120. Pfizer SWOT Analysis

Table 121. Pfizer Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 122. Pfizer Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 123. GE Healthcare Corporate Information, Location and Competitors

Table 124. GE Healthcare Major Business

Table 125. GE Healthcare Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 126. GE Healthcare SWOT Analysis

Table 127. GE Healthcare Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 128. GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 129. Teva Pharmaceutical Corporate Information, Location and Competitors

Table 130. Teva Pharmaceutical Major Business

Table 131. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 132. Teva Pharmaceutical SWOT Analysis

Table 133. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 134. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 135. Tolmar Pharmaceuticals Corporate Information, Location and Competitors

Table 136. Tolmar Pharmaceuticals Major Business

Table 137. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)

Table 138. Tolmar Pharmaceuticals SWOT Analysis

Table 139. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product and Solutions

Table 140. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 141. Global Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Players (2015-2020)

Table 142. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Players (2015-2020)

Table 143. Key Players Prostate Cancer Diagnosis and Treatment Revenue (USD Million) in China (2015-2020)

Table 144. Key Players Prostate Cancer Diagnosis and Treatment Revenue Share in China (2015-2020)

Table 145. North America Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Countries (2015-2020)

Table 146. North America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)

Table 147. North America Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Countries (2020-2026)

Table 148. North America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2020-2026)

Table 149. Europe Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Countries (2015-2020)

Table 150. Europe Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)

Table 151. Europe Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Countries (2020-2026)

Table 152. Europe Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2020-2026)

Table 153. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Countries (2015-2020)

Table 154. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)

Table 155. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Countries (2020-2026)

Table 156. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2020-2026)

Table 157. South America Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Countries (2015-2020)

Table 158. South America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)

Table 159. South America Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Countries (2020-2026)

Table 160. South America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2020-2026)

Table 161. Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Countries (2015-2020)

Table 162. Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)

Table 163. Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Countries (2020-2026)

Table 164. Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2020-2026)

Table 165. Global Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Type (2015-2020)

Table 166. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Type (2015-2020)

Table 167. Global Prostate Cancer Diagnosis and Treatment Revenue Forecast by Type (2020-2025)

Table 168. Global Prostate Cancer Diagnosis and Treatment Market Share Forecast by Type (2020-2025)

Table 169. China Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Type (2015-2020)

Table 170. China Prostate Cancer Diagnosis and Treatment Revenue Share by Type (2015-2020)

Table 171. China Prostate Cancer Diagnosis and Treatment Revenue Forecast by Type (2020-2025)

Table 172. China Prostate Cancer Diagnosis and Treatment Market Share Forecast by Type (2020-2025)

Table 173. Global Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Application (2015-2020)

Table 174. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Application (2015-2020)

Table 175. Global Prostate Cancer Diagnosis and Treatment Revenue Forecast by Application (2020-2025)

Table 176. Global Prostate Cancer Diagnosis and Treatment Market Share Forecast by Application (2020-2025)

Table 177. China Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Application (2015-2020)

Table 178. China Prostate Cancer Diagnosis and Treatment Revenue Share by Application (2015-2020)

Table 179. China Prostate Cancer Diagnosis and Treatment Revenue Forecast by Application (2020-2025)

Table 180. China Prostate Cancer Diagnosis and Treatment Market Share Forecast by Application (2020-2025)

List of Figures

Figure 1. Prostate Cancer Diagnosis and Treatment Picture

Figure 2. Global Prostate Cancer Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 3. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type in 2019

Figure 4. Prostate specific antigen test (PSA) Picture

Figure 5. Digital rectal exam (DRE) Picture

Figure 6. Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application in 2019

Figure 7. Hospitals Picture

Figure 8. Diagnostic clinics Picture

Figure 9. Research centers Picture

Figure 10. Global Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2025) (USD Million)

Figure 11. Global Prostate Cancer Diagnosis and Treatment Market Size Share by Regions (2015-2025)

Figure 12. Global Prostate Cancer Diagnosis and Treatment Market Size Share by Regions in 2019

Figure 13. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Regions (2020-2025)

Figure 14. North America Prostate Cancer Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2015-2025)

Figure 15. Europe Prostate Cancer Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2015-2025)

Figure 16. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2015-2025)

Figure 17. South America Prostate Cancer Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2015-2025)

Figure 18. Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2015-2025)

Figure 19. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Players in 2019

Figure 20. Global Top 5 Players Prostate Cancer Diagnosis and Treatment Revenue Market Share in 2019

Figure 21. Top 10 Players Prostate Cancer Diagnosis and Treatment Revenue Market Share in Global Market in 2019

Figure 22. Global Prostate Cancer Diagnosis and Treatment Market Size (USD Million) by Type (2015-2025)

Figure 23. Global Prostate Cancer Diagnosis and Treatment Market Size Share by Application (2015-2025)

Figure 24. North America Prostate Cancer Diagnosis and Treatment Market Size Share by Countries (2015-2025)

Figure 25. North America Prostate Cancer Diagnosis and Treatment Market Size Share by Countries in 2019

Figure 26. United States Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 27. Canada Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 28. Mexico Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 29. Europe Prostate Cancer Diagnosis and Treatment Market Size Share by Countries (2015-2025)

Figure 30. Europe Prostate Cancer Diagnosis and Treatment Market Size Share by Countries in 2019

Figure 31. Germany Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 32. France Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 33. Russia Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 34. Italy Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 35. Spain Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 36. UK Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 37. Asia Prostate Cancer Diagnosis and Treatment Market Size Share by Countries (2015-2025)

Figure 38. Asia Prostate Cancer Diagnosis and Treatment Market Size Share by Countries in 2019

Figure 39. China Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 40. Japan Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 41. Korea Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 42. India Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 43. Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 44. South America Prostate Cancer Diagnosis and Treatment Market Size Share by Countries (2015-2025)

Figure 45. South America Prostate Cancer Diagnosis and Treatment Market Size Share by Countries in 2019

Figure 46. Brazil Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 47. Argentina Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 48. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size Share by Countries (2015-2025)

Figure 49. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size Share by Countries in 2019

Figure 50. Saudi Arabia Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 51. UAE Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 52. Egypt Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 53. South Africa Prostate Cancer Diagnosis and Treatment Market Size (USD Million) and Forecast (2015-2025)

Figure 54. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Type (2015-2020)

Figure 55. China Prostate Cancer Diagnosis and Treatment Revenue Share by Type (2015-2020)

Figure 56. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Application (2015-2020)

Figure 57. China Prostate Cancer Diagnosis and Treatment Revenue Share by Application (2015-2020)